Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant Recipients

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 7, 2011, Pages 1043-1050

  Nguyen, M Hong ^a   Leather, Helen ^b   Clancy, Cornelius J ^a   Cline, Christina ^b   Jantz, Michael A ^b   Kulkarni, Varsha ^b   Wheat, L Joseph ^c   Wingard, John R ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c MIRAVISTA DIAGNOSTICS   (United States)

Author keywords

Aspergillosis; Bronchoalveolar lavage; Diagnostic; Galactomannan

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; CEFEPIME; FLUCONAZOLE; GALACTOMANNAN; VORICONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIBIOTIC THERAPY; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; DISEASE ASSOCIATION; FEBRILE NEUTROPENIA; FEMALE; GRAFT RECIPIENT; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LUNG ASPERGILLOSIS; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TRANSBRONCHIAL BIOPSY;

AGED; ANTIFUNGAL AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPERGILLUS FUMIGATUS; BIOLOGICAL MARKERS; BIOPSY; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; INVASIVE PULMONARY ASPERGILLOSIS; MALE; MANNANS; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PYRIMIDINES; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TRIAZOLES;

EID: 79958702180     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.11.013     Document Type: Article

References (36)

1. Patterson T.F., Kirkpatrick W.R., White M., et al. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine (Baltimore) 2000, 79:250-260.
2. Grow W.B., Moreb J.S., Roque D., et al. Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital. Bone Marrow Transplant 2002, 29:15-19.
3. Marr K.A., Carter R.A., Crippa F., Wald A., Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002, 34:909-917.
4. Fukuda T., Boeckh M., Carter R.A., et al. Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood 2003, 102:827-833.
5. Lin S.J., Schranz J., Teutsch S.M. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001, 32:358-366.
6. Neofytos D., Horn D., Anaissie E., et al. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis 2009, 48:265-273.
7. Greene R.E., Schlamm H.T., Oestmann J.W., et al. Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin Infect Dis 2007, 44:373-379.
8. von Eiff M., Roos N., Schulten R., Hesse M., Zuhlsdorf M., van de Loo J. Pulmonary aspergillosis: early diagnosis improves survival. Respiration 1995, 62:341-347.
9. Caillot D., Couaillier J.F., Bernard A., et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol 2001, 19:253-259.
10. Knox K.S., Meinke L. Role of bronchoalveolar lavage diagnostics in fungal infections. Clin Chest Med 2009, 30:355-365. viii.
11. Reichenberger F., Habicht J., Matt P., et al. Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosis. Bone Marrow Transplant 1999, 24:1195-1199.
12. Mennink-Kersten M.A., Donnelly J.P., Verweij P.E. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 2004, 4:349-357.
13. Leeflang M.M., Debets-Ossenkopp Y.J., Visser C.E., et al. Galactomannan detection for invasive aspergillosis in immunocompromized patients. Cochrane Database Syst Rev 2008, CD007394.
14. Pfeiffer C.D., Fine J.P., Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 2006, 42:1417-1427.
15. Becker M.J., Lugtenburg E.J., Cornelissen J.J., Van Der Schee C., Hoogsteden H.C., De Marie S. Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis. Br J Haematol 2003, 121:448-457.
16. Bergeron A., Belle A., Sulahian A., et al. Contribution of galactomannan antigen detection in bronchoalveolar lavage to the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies. Chest 2010, 137:410-415.
17. Maertens J., Buve K., Theunissen K., et al. Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients. Cancer 2009, 115:355-362.
18. Musher B., Fredricks D., Leisenring W., Balajee S.A., Smith C., Marr K.A. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J Clin Microbiol 2004, 42:5517-5522.
19. Salonen J., Lehtonen O.P., Terasjarvi M.R., Nikoskelainen J. Aspergillus antigen in serum, urine and bronchoalveolar lavage specimens of neutropenic patients in relation to clinical outcome. Scand J Infect Dis 2000, 32:485-490.
20. Sanguinetti M., Posteraro B., Pagano L., et al. Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol 2003, 41:3922-3925.
21. Seyfarth H.J., Nenoff P., Winkler J., Krahl R., Haustein U.F., Schauer J. Aspergillus detection in bronchoscopically acquired material. Significance and interpretation. Mycoses 2001, 44:356-360.
22. Siemann M., Koch-Dorfler M. The Platelia Aspergillus ELISA in diagnosis of invasive pulmonary aspergillosis (IPA). Mycoses 2001, 44:266-272.
23. Becker M.J., de Marie S., Willemse D., Verbrugh H.A., Bakker-Woudenberg I.A. Quantitative galactomannan detection is superior to PCR in diagnosing and monitoring invasive pulmonary aspergillosis in an experimental rat model. J Clin Microbiol 2000, 38:1434-1438.
24. Maertens J., Maertens V., Theunissen K., et al. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clin Infect Dis 2009, 49:1688-1693.
25. Verweij P.E., Latge J.P., Rijs A.J., et al. Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies. J Clin Microbiol 1995, 33:3150-3153.
26. Clancy C.J., Jaber R.A., Leather H.L., et al. Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients. J Clin Microbiol 2007, 45:1759-1765.
27. Nguyen M.H., Jaber R., Leather H.L., et al. Use of bronchoalveolar lavage to detect galactomannan for diagnosis of pulmonary aspergillosis among nonimmunocompromised hosts. J Clin Microbiol 2007, 45:2787-2792.
28. De Pauw B., Walsh T.J., Donnelly J.P., et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008, 46:1813-1821.
29. Donnelly J.P., Leeflang M.M. Galactomannan detection and diagnosis of invasive aspergillosis. Clin Infect Dis 2010, 50:1070-1071. author reply 1071-1072.
30. Wheat L.J. Rapid diagnosis of invasive aspergillosis by antigen detection. Transpl Infect Dis 2003, 5:158-166.
31. Hage C.A., Reynolds J.M., Durkin M., Wheat L.J., Knox K.S. Plasmalyte as a cause of false-positive results for Aspergillus galactomannan in bronchoalveolar lavage fluid. J Clin Microbiol 2007, 45:676-677.
32. Marr K.A., Balajee S.A., McLaughlin L., Tabouret M., Bentsen C., Walsh T.J. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis 2004, 190:641-649.
33. Marr K.A., Laverdiere M., Gugel A., Leisenring W. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis 2005, 40:1762-1769.
34. Francesconi A., Kasai M., Petraitiene R., et al. Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis. J Clin Microbiol 2006, 44:2475-2480.
35. Petraitis V., Petraitiene R., Sarafandi A.A., et al. Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin. J Infect Dis 2003, 187:1834-1843.
36. Hope W.W., Kruhlak M.J., Lyman C.A., et al. Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: implications for antifungal therapy. J Infect Dis 2007, 195:455-466.